(BYRN) Byrna Technologies - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NASDAQ (USA) | Market Cap: 126m USD | Total Return: -78.4% in 12m
Avg Turnover: 2.21M
Qual. Beats: 0
Rev. Trend: 96.9%
Qual. Beats: 0
Warnings
Earnings expected to drop: P/E 15.4 → Forward 32.5
Beneish M-Score -0.99 > -1.5 - likely earnings manipulation
Altman Z'' -0.63 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
Byrna Technologies Inc. (BYRN) specializes in the development and manufacture of non-lethal personal security solutions, including handheld and shoulder-fired launchers. Headquartered in Andover, Massachusetts, the company serves both consumer and professional security markets across North America, South Africa, Europe, and Asia. Its product ecosystem includes chemical irritant projectiles, kinetic rounds, and integrated safety accessories like body armor and aerosol repellents.
The company operates within the specialized defense technology sector, focusing on products that generally do not require a firearms license or background check for purchase. This business model leverages a multi-channel distribution strategy, utilizing direct-to-consumer e-commerce platforms alongside a network of outdoor and sporting goods retailers. By targeting the less-lethal niche, the company addresses a growing market for self-defense tools that occupy the space between traditional firearms and passive security measures.
For more detailed financial analysis and historical performance metrics, consider reviewing the comprehensive data available on ValueRay.
- Direct-to-consumer marketing success drives record e-commerce revenue and customer acquisition
- Celebrity endorsements and media appearances trigger immediate spikes in hardware sales
- Regulatory shifts in firearm laws increase demand for less-lethal alternatives
- Expansion into big-box retail and international markets diversifies global revenue streams
- Production scalability and supply chain efficiency determine gross margin performance
| Net Income: 8.83m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.10 > 0.02 and ΔFCF/TA -8.67 > 1.0 |
| NWC/Revenue: 39.16% < 20% (prev 38.38%; Δ 0.78% < -1%) |
| CFO/TA -0.03 > 3% & CFO -2.22m > Net Income 8.83m |
| Net Debt (-7.04m) to EBITDA (13.7m): -0.51 < 3 |
| Current Ratio: 4.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.8m) vs 12m ago -1.12% < -2% |
| Gross Margin: 60.30% > 18% (prev 0.62%; Δ 5.97k% > 0.5%) |
| Asset Turnover: 160.3% > 50% (prev 134.1%; Δ 26.16% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.59 (Total Current Assets 59.3m - Total Current Liabilities 12.0m) / Total Assets 79.9m |
| B: -0.58 (Retained Earnings -46.3m / Total Assets 79.9m) |
| C: 0.15 (EBIT TTM 11.4m / Avg Total Assets 75.5m) |
| D: -3.47 (Book Value of Equity -46.6m / Total Liabilities 13.4m) |
| Altman-Z'' = -0.63 = B |
| DSRI: 3.14 (Receivables 11.6m/2.90m, Revenue 121.0m/95.3m) |
| GMI: 1.03 (GM 60.30% / 61.97%) |
| AQI: 0.86 (AQ_t 0.14 / AQ_t-1 0.16) |
| SGI: 1.27 (Revenue 121.0m / 95.3m) |
| TATA: 0.14 (NI 8.83m - CFO -2.22m) / TA 79.9m) |
| Beneish M = -0.99 (Cap -4..+1) = D |
As of May 26, 2026, the stock is trading at USD 5.54 with a total of 249,800 shares traded.
Over the past week, the price has changed by +11.69%,
over one month by -7.82%,
over three months by -58.72% and
over the past year by -78.44%.
Byrna Technologies has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy BYRN.
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 13.7 | 146.8% |
P/E Trailing = 15.3889
P/E Forward = 32.4675
P/S = 1.0388
P/B = 1.8834
Revenue TTM = 121.0m USD
EBIT TTM = 11.4m USD
EBITDA TTM = 13.7m USD
Long Term Debt = 1.42m USD (estimated: total debt 2.17m - short term 751k)
Short Term Debt = 751k USD (from shortTermDebt, last quarter)
Debt = 2.17m USD (from shortLongTermDebtTotal, last quarter) (leases 2.17m already included)
Net Debt = -7.04m USD (calculated: Debt 2.17m - CCE 9.21m)
Enterprise Value = 118.6m USD (125.7m + Debt 2.17m - CCE 9.21m)
Interest Coverage Ratio = unknown (Ebit TTM 11.4m / Interest Expense TTM 0.0)
EV/FCF = -15.17x (Enterprise Value 118.6m / FCF TTM -7.82m)
FCF Yield = -6.59% (FCF TTM -7.82m / Enterprise Value 118.6m)
FCF Margin = -6.46% (FCF TTM -7.82m / Revenue TTM 121.0m)
Net Margin = 7.30% (Net Income TTM 8.83m / Revenue TTM 121.0m)
Gross Margin = 60.30% ((Revenue TTM 121.0m - Cost of Revenue TTM 48.0m) / Revenue TTM)
Gross Margin QoQ = 59.90% (prev 59.75%)
Tobins Q-Ratio = 1.48 (Enterprise Value 118.6m / Total Assets 79.9m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 2.17m)
Taxrate = 17.49% (2.05m / 11.7m)
NOPAT = 9.41m (EBIT 11.4m * (1 - 17.49%))
Current Ratio = 4.96 (Total Current Assets 59.3m / Total Current Liabilities 12.0m)
Debt / Equity = 0.03 (Debt 2.17m / totalStockholderEquity, last quarter 66.5m)
Debt / EBITDA = -0.51 (Net Debt -7.04m / EBITDA 13.7m)
Debt / FCF = 0.90 (negative FCF - burning cash) (Net Debt -7.04m / FCF TTM -7.82m)
Total Stockholder Equity = 63.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.70% (Net Income 8.83m / Total Assets 79.9m)
RoE = 8.01% (Net Income TTM 8.83m / Total Stockholder Equity 110.2m)
RoCE = 10.22% (EBIT 11.4m / Capital Employed (Equity 110.2m + L.T.Debt 1.42m))
RoIC = 15.82% (NOPAT 9.41m / Invested Capital 59.5m)
WACC = 8.58% (E(125.7m)/V(127.8m) * Re(8.73%) + D(2.17m)/V(127.8m) * Rd(0.0%) * (1-Tc(0.17)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 64.44 | Cagr: 3.63%
[DCF] Fair Price = unknown (Cash Flow -7.82m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.28 | # QB: 0
Revenue Correlation: 96.87 | Revenue CAGR: 54.22% | SUE: -0.39 | # QB: 0
EPS current Quarter (2026-05-31): EPS=-0.12 | Chg30d=-220.00% | Revisions=-20% | Analysts=1
EPS next Quarter (2026-08-31): EPS=-0.11 | Chg30d=-210.00% | Revisions=-20% | Analysts=1
EPS current Year (2026-11-30): EPS=-0.11 | Chg30d=-126.83% | Revisions=-20% | GrowthEPS=-121.3% | GrowthRev=-4.0%
EPS next Year (2027-11-30): EPS=0.06 | Chg30d=-89.29% | Revisions=-20% | GrowthEPS=+154.6% | GrowthRev=+10.6%